Analysis of Airway Responses in Severe COPD Patients to Daxas Using CT Based Functional Respiratory Imaging.

Trial Profile

Analysis of Airway Responses in Severe COPD Patients to Daxas Using CT Based Functional Respiratory Imaging.

Completed
Phase of Trial: Phase IV

Latest Information Update: 02 May 2014

At a glance

  • Drugs Roflumilast (Primary)
  • Indications Chronic obstructive pulmonary disease
  • Focus Therapeutic Use
  • Sponsors FLUIDDA
  • Most Recent Events

    • 20 Nov 2012 Planned end date changed from 1 Nov 2012 to 1 Apr 2013 as reported by ClinicalTrials.gov.
    • 20 Nov 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 29 Sep 2012 New source identified and integrated (European Clinical Trials Database; EudraCT2011-004271-36).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top